Article ID Journal Published Year Pages File Type
2894703 Atherosclerosis 2007 9 Pages PDF
Abstract

Elevated plasma asymmetric dimethylarginine (ADMA) concentrations have been suggested as a potential risk factor for cardiovascular disease (CVD). Studies indicate a linkage between hyperhomocysteinemia, oxidative stress and ADMA metabolism. We tested the hypothesis that combined supplementation of B vitamins and antioxidants reduces ADMA concentrations in subjects with at least two CVD risk factors. A total of 123 men and women (58 ± 8.1 years) were randomly assigned to take either a preparation including B vitamins and antioxidants (verum) or placebo for 6 months in a double-blind design. Blood concentrations of ADMA, symmetric dimethylarginine (SDMA), l-arginine, B vitamins, total homocysteine (tHcy), α-tocopherol, antioxidant capacity (TEAC), and oxLDL were measured pre- and post-intervention. Treatment with verum significantly decreased tHcy (−2.14 μmol/L; P < 0.001) and significantly increased TEAC values (+39.3 μM; P < 0.022), but no effect on ADMA was observed. OxLDL was significantly reduced in verum (−7.3 U/L; P = 0.001) and placebo (−9.2 U/L; P < 0.001). At baseline, significant correlations were found only between ADMA and SDMA (r = 0.281; P = 0.002), l-arginine/ADMA and SDMA (r = −0.294; P < 0.001), l-arginine/ADMA and oxLDL (r = −0.281; P = 0.016), and l-arginine/ADMA and age (r = −0.231; P = 0.010). Our results indicate that combined supplementation of B vitamins and antioxidants is not an adequate strategy to reduce ADMA plasma levels in subjects with elevated CVD risk.

Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , , , , , ,